Consolidated Statement of Changes in Stockholders' (Deficit) Equity - USD ($) |
Total |
Private Equity Offering One |
Private Equity Offering Two |
Conversion Features One |
Conversion Features Two |
Conversion Features Three |
Conversion Features Four |
Exercise Price 1 |
Exercise Price 2 |
Preferred Stock |
Preferred Stock
Series B Convertible Preferred Stock
|
Common Stock |
Common Stock
Series B Convertible Preferred Stock
|
Common Stock
Private Equity Offering One
|
Common Stock
Private Equity Offering Two
|
Common Stock
Conversion Features Two
|
Common Stock
Conversion Features Three
|
Common Stock
Conversion Features Four
|
Common Stock
Exercise Price 1
|
Common Stock
Exercise Price 2
|
Additional Paid-in Capital |
Additional Paid-in Capital
Private Equity Offering One
|
Additional Paid-in Capital
Private Equity Offering Two
|
Additional Paid-in Capital
Conversion Features One
|
Additional Paid-in Capital
Conversion Features Two
|
Additional Paid-in Capital
Conversion Features Three
|
Additional Paid-in Capital
Conversion Features Four
|
Additional Paid-in Capital
Exercise Price 1
|
Additional Paid-in Capital
Exercise Price 2
|
Accumulated Deficit |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Beginning balance at May. 31, 2015 | $ (10,692,516) | $ 95 | $ 63,644 | $ 60,766,047 | $ (71,522,302) | |||||||||||||||||||||||||
Beginning balance, shares at May. 31, 2015 | 95,100 | 63,644,348 | ||||||||||||||||||||||||||||
Interest expense related to warrant extension | $ 757,871 | $ 757,871 | ||||||||||||||||||||||||||||
Debt discount due to reduction in note conversion price from ($0.75 to $0.675/share) | 329,524 | 329,524 | ||||||||||||||||||||||||||||
Stock-based compensation | 2,353,194 | 2,353,194 | ||||||||||||||||||||||||||||
Modification of warrants related to conversion inducement | $ 866,713 | $ 866,713 | ||||||||||||||||||||||||||||
Conversion of convertible debt and extinguishment of derivative liability, Value | $ 4,732,514 | $ 5,275 | $ 4,727,239 | |||||||||||||||||||||||||||
Conversion of convertible debt and extinguishment of derivative liability, shares | $ 5,274,656 | |||||||||||||||||||||||||||||
Proceeds from private equity offering, shares | 44,357,838 | 4,301,500 | ||||||||||||||||||||||||||||
Proceeds from private equity offering, value | $ 33,268,464 | $ 4,301,500 | $ 44,358 | $ 4,302 | $ 33,224,106 | $ 4,297,198 | ||||||||||||||||||||||||
Common shares issued to extinguish promissory notes payable, convertible debt and related interest, shares | 4,095,008 | 792,201 | ||||||||||||||||||||||||||||
Common shares issued to extinguish promissory notes payable, convertible debt and related interest, value | $ 2,764,154 | $ 594,152 | $ 4,095 | $ 792 | $ 2,760,059 | $ 593,360 | ||||||||||||||||||||||||
Proceeds from warrant exercise, shares | 192,307 | 603,286 | ||||||||||||||||||||||||||||
Proceeds from warrant exercise, value | $ 96,154 | $ 452,465 | $ 192 | $ 604 | $ 95,962 | $ 451,861 | ||||||||||||||||||||||||
Cashless exercise of warrants, shares | 74,490 | |||||||||||||||||||||||||||||
Cashless exercise of warrants, value | $ 74 | (74) | ||||||||||||||||||||||||||||
Deferred offering costs | (3,915,127) | (3,915,127) | ||||||||||||||||||||||||||||
Net (loss) at year ended | (25,703,612) | (25,703,612) | ||||||||||||||||||||||||||||
Ending balance at May. 31, 2016 | 10,205,450 | $ 95 | $ 123,336 | 107,307,933 | (97,225,914) | |||||||||||||||||||||||||
Ending balance, shares at May. 31, 2016 | 95,100 | 123,335,634 | ||||||||||||||||||||||||||||
Proceeds from Registered Direct Offering ($0.75/share), shares | 24,538,994 | |||||||||||||||||||||||||||||
Interest expense related to warrant extension | 72,434 | $ 36 | 72,398 | |||||||||||||||||||||||||||
Stock-based compensation | 1,204,791 | 1,204,791 | ||||||||||||||||||||||||||||
Legal fees in connection with registered offerings | (280,883) | (280,883) | ||||||||||||||||||||||||||||
Proceeds from private equity offering, shares | 729,500 | |||||||||||||||||||||||||||||
Proceeds from private equity offering, value | $ 729,500 | $ 730 | $ 728,770 | |||||||||||||||||||||||||||
Proceeds from Registered Direct Offering ($0.75/share), value | 14,044,252 | $ 24,539 | 14,019,713 | |||||||||||||||||||||||||||
Common shares issued to extinguish promissory notes payable, convertible debt and related interest, shares | (3,000) | 40,602 | ||||||||||||||||||||||||||||
Offering costs related to equity offering | (1,804,249) | (1,804,249) | ||||||||||||||||||||||||||||
Common shares issued to extinguish promissory notes payable, convertible debt and related interest, value | $ (3) | $ 3 | ||||||||||||||||||||||||||||
Debt discount related to convertible notes payable | 91,389 | 91,389 | ||||||||||||||||||||||||||||
Proceeds from warrant exercise, shares | 730,765 | 43,332 | ||||||||||||||||||||||||||||
Proceeds from warrant exercise, value | $ 365,383 | $ 32,500 | $ 730 | $ 44 | $ 364,653 | $ 32,456 | ||||||||||||||||||||||||
Cashless exercise of warrants, shares | 49,417 | |||||||||||||||||||||||||||||
Cashless exercise of warrants, value | $ 50 | (50) | ||||||||||||||||||||||||||||
Net (loss) at year ended | (25,763,801) | (25,763,801) | ||||||||||||||||||||||||||||
Ending balance at May. 31, 2017 | $ (1,103,234) | $ 92 | $ 149,468 | $ 121,736,921 | $ (122,989,715) | |||||||||||||||||||||||||
Ending balance, shares at May. 31, 2017 | 92,100 | 149,468,244 |